Rare Cancers Australia founder and CEO Richard Vines sat down for a discussion with BioPharmaDispatch. He challenged the early direction of the health technology assessment review and called on health minister Mark Butler to set clear expectations for the process while saying it cannot be credibly conducted behind closed doors. …
Richard Vines: A better designed spreadsheet is not going to help anybody
February 22, 2023 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
Georgia Forrest
New Stories
-
Anne Harris steps down after defining leadership during COVID and lasting impact on Medicines Australia
January 14, 2026 - - Latest News -
AusBiotech joins Trade Diversification Network to boost global life sciences partnerships
January 13, 2026 - - Australian Biotech -
Reread this document - even its redactions reveal that change might be coming
January 13, 2026 - - Latest News -
Johnson & Johnson the latest to sign 'Most Favored Nation' agreement with Trump administration
January 11, 2026 - - Latest News -
Reading between the reform lines - what the 2005 Cabinet papers can teach us today
January 11, 2026 - - Latest News -
New treatment listed on PBS, offering twice-yearly dosing for Australians with relapsing MS
January 9, 2026 - - Latest News -
The value of looking back and the importance of seeing the 'smoke signals' on reform
January 8, 2026 - - Latest News